Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 25

Showing 25 citing articles:

Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 8
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
Gene expression profiling to uncover prognostic and therapeutic targets in colon cancer, combined with docking and dynamics studies to discover potent anticancer inhibitor
Mohammad Kashif
Computational Biology and Chemistry (2025) Vol. 115, pp. 108349-108349
Closed Access
Volatile Organic Compound–Drug Receptor Interactions: A Potential Tool for Drug Design in the Search for Remedies for Increasing Toxic Occupational Exposure
John Onyebuchi Ogbodo, Simeon Ikechukwu Egba, Gavin Chibundu Ikechukwu, et al.
Processes (2025) Vol. 13, Iss. 1, pp. 154-154
Open Access
Identification of Natural Phytochemicals as AKT2 Inhibitors Using Molecular Docking and Dynamics Simulations as Potential Cancer Therapeutics
Jibon Kumar Paul, Mahir Azmal, Md. Naimul Haque Shohan, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41897-e41897
Open Access
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Masaud Shah, Muhammad Hussain, Hyun Goo Woo
Genomics & Informatics (2025) Vol. 23, Iss. 1
Open Access
Targeting SLC4A4: A Novel Approach in Colorectal Cancer Drug Repurposing
Krunal Pawar, Pramodkumar P. Gupta, Pooran Singh Solanki, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 67-67
Open Access
Cancer nanomedicine: Smart arsenal in the war against cancer
Muneeb Ullah, Uzma Azeem Awan, Abdul Muhaymin, et al.
Inorganic Chemistry Communications (2025), pp. 114030-114030
Closed Access
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Assessment of Antidiarrheal Effect of Oleuropein Through µ‐Oopioid Receptor Interaction Pathway: In Vivo and in Silico Studies
Nishat Jahan, Manoj Mandal, Imam Hossen Rakib, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Nanoparticles of Natural Product-derived Medicines: Beyond the Pandemic
Yedi Herdiana
Heliyon (2025) Vol. 11, Iss. 4, pp. e42739-e42739
Open Access
Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities
Md. Ataur Rahman, Maroua Jalouli, Mahesh Kumar Yadab, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 701-701
Open Access
Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems
Sivakumar S. Moni, Jobran M. Moshi, Sabine Matou‐Nasri, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 296-296
Open Access
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
Pankaj Garg, Sravani Ramisetty, Meera G. Nair, et al.
Biochemical Pharmacology (2025), pp. 116850-116850
Open Access
MED12 dysregulation: insights into cancer and therapeutic resistance
Ritesh Bhole, Jagruti Shinkar, Sonali Labhade, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Combination of 10-hydroxy-decanoic acid and ZnO nanoparticles abrogates lead acetate-induced nephrotoxicity in rats: targeting oxidative stress and inflammatory signalling
Samar R. Saleh, Raheel G. Agwah, Samar S. Elblehi, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Current Research in Drug-Free Cancer Therapies
Akshaya Andavar, Varsha Rajesh Bhagavathi, J Cousin, et al.
Bioengineering (2025) Vol. 12, Iss. 4, pp. 341-341
Open Access
Antibody-drug conjugates and radioconjugates targeting carbonic anhydrase IX and XII in hypoxic tumors: Bench to clinical applications
Sridhar Goud Nerella, Shaik Mahammad Ghouse, Priti Singh, et al.
Bioorganic Chemistry (2025), pp. 108408-108408
Closed Access
Warhead-bearing natural compounds for multi-pathway irreversible inhibition to overcome drug resistance in colorectal cancer
Hua-ping Hou, Xinqi Liu, Wentao Liu, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives
Bruno Cerra, Antimo Gioiello
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Role of metabolic transformation in cancer immunotherapy resistance: molecular mechanisms and therapeutic implications
Sandesh Shende, Jaishriram Rathored, Tanushree Budhbaware
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Potential of Carbon Nanodots (CNDs) in Cancer Treatment
Walaa Alibrahem, Nihad Kharrat Helu, Csaba Oláh, et al.
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 560-560
Open Access
Antioxidant activity and selective cytotoxicity in HCT-116 and WI-38 cell lines of LC-MS/MS profiled extract from Capparis spinosa L
Amjad Ibrahim Oraibi, Ashour H. Dawood, Ghada Trabelsi, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Page 1

Scroll to top